Molecular Targets in Alzheimer’s Disease: From Mechanisms to Therapeutic Strategies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 September 2026 | Viewed by 1174
Special Issue Editor
Special Issue Information
Dear Colleagues,
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, characterized by loss of memory and cognition. Understanding, the molecular mechanism underlying the progression of AD is essential to understanding the potential cause of disease. Investigating this mechanism can provide valuable insight into the development of targeted therapeutic strategy.
Aim: 1) To explain molecular mechanism behind Aβ deposition and Tau phosphorylation; 2) To study the potential role of inflammation in progression of AD pathology; 3) To identify early biomarkers for the diagnosis of AD.
Potential topic:
- The role of Amyloid-beta and Tau Interactions in AD associated neurodegeneration.
- Microglial in Alzheimer’s disease and its role in neuroinflammation.
- Mitochondrial fission and fusion in Alzheimer’s disease.
- Role of inflammation in early and late onset of Alzheimer’s disease and therapeutic implication.
- Neurovascular dysfunction and amyloid angiopathy in Alzheimer’s disease.
Dr. Mohammad Ejaz Ahmed
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- amyloid beta
- neurodegeneration
- neuroinflammation
- microglia
- mitochondrial dysfucntion
- oxidative stress
- molecular pathway
- biomarkers of AD
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
